Medicine and Dentistry
Prostate Specific Membrane Antigen
100%
Immune Response
100%
Prostate Cancer
83%
Nucleic Acid
66%
Cancer Vaccine
66%
Therapeutic Procedure
50%
Immunotherapy
33%
Castration Resistant Prostate Cancer
33%
Immunoglobulin
33%
Diseases
33%
Cells
33%
Inpatient
33%
Aptitude
33%
Oncology
33%
Progression Free Survival
16%
Therapeutic Agent
16%
Cell Therapy
16%
Antibody
16%
Cancer Cell
16%
Immunomodulating Agent
16%
Sipuleucel T
16%
Nanoparticle
16%
Antigen
16%
Cell Activity
16%
Tumor Antigen
16%
Neoplasm
16%
Overall Survival
16%
Tenidap
16%
Evaluation Study
16%
Malignant Neoplasm
16%
T Cell
16%
Development
16%
Medical Oncology
16%
Patient
16%
Surgery
16%
Therapeutic Vaccine
16%
Antigen Presenting Cell
8%
Tumor Immunology
8%
Programmed Death-Ligand 1
8%
Clinical Trial
8%
Immunology and Microbiology
Immune Response
100%
Prostate Specific Membrane Antigen
100%
Cancer Vaccine
66%
Animal
50%
Cells
50%
Prostate
50%
Aptitude
33%
Intravenous Immunoglobulin
33%
Immunotherapy
33%
Mouse Model
33%
Cell Activity
16%
Vaccine Efficacy
16%
Antigen
16%
Synthesis
16%
Tumor-Associated Antigen
16%
Cancer Cell
16%
Progression Free Survival
16%
Overall Survival
16%
Sipuleucel-T
16%
Monospecific Antibody
16%
Electric Potential
16%
Development
16%
Immunomodulating Drugs
16%
Programmed Death-Ligand 1
8%
Tumor Immunology
8%
INIS
prostate
100%
cancer
92%
antigens
69%
membranes
46%
vaccines
38%
nucleic acids
30%
animals
23%
patients
23%
tumors
23%
diseases
15%
oligonucleotides
15%
metastases
15%
mice
15%
castration
15%
immunotherapy
15%
design
7%
nanoparticles
7%
mimic
7%
increasing
7%
refining
7%
production
7%
therapy
7%
therapeutic agents
7%
immunology
7%
chemistry
7%
antibodies
7%
synthesis
7%
evaluation
7%
surgery
7%
clinical trials
7%
yields
7%
nanotechnology
7%
humans
7%
interactions
7%
nanostructures
7%